| Unique ID | iCARE-FD-0051 |
| Prefix / Honorific (optional) (Prefix) | Miss |
| First or given name (First name) | Frédérique |
| Last or family name (Last name) | Deslauriers |
| Email (Enter your email) | deslauriers.frederique@courrier.uqam.ca |
| Other investigators or team members (optional) | Camille Léger, Simon Bacon, Kim Lavoie |
| Institution | Université du Québec à Montréal |
| Country (Country) | Canada |
| Analysis Plan Title | Motivators for getting the COVID-19 booster : Canada, Colombia and Italy – Result of the iCARE study |
| Analysis Plan Description | This study aims to examine the prevalence, sociodemographic predictors, and motivators of COVID-19 booster vaccination in 3 countries that faced significant COVID-19 burden: Ireland (IRE), Italy (ITA) and Colombia (COL). A series of representative samples from IRE, ITA and COL (N ≈ 2000 per country) between January 2022 and June 2022 will be used for this project. Respondents self-reported their vaccine status, characteristics, and motivators for getting a booster. General linear models (GLM’s) were used to estimate differences between countries in terms of prevalence, sociodemographic predictors, and motivators. |
| Keyword 1 | COVID-19 |
| Keyword 2 | Vaccination |
| Keyword 3 (optional) | Booster |
| Keyword 4 (optional) | Motivators |
| Keyword 5 (optional) | International |
| Representative data | Representative data |
| Representative Samples – Choose country | Canada, Colombia, Italy |
| Data Time Frame – Specific Survey (Representative – Canada) | January 20-February 2, 2022, May 26-June 6, 2022 |
| Data Time Frame – Specific Survey (Representative – Italy) | February 3-6, 2022, May 23-29, 2022 |
| Data Time Frame – Specific Survey (Representative – Colombia) | January 26-February 2, 2022, May 24-June 1, 2022 |
| Analysis outputs (optional) | Submission APS 2023 Puerto Rico, abstract submission closes 13th October 2022. |
| Target completion date (optional) | 29-09-22 |
| Entry Date | 15-09-22 19:01 |
| Last update | 2023-03-20: Analysis presented at the ASP convention March 2023 |
